NRX Pharmaceuticals, Inc.
NRXP • NASDAQ
NRX Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jonathan C. Javitt, with a market cap of $72.4M.
Market Cap$72.4M
CEOJonathan C. Javitt
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 14, 2026 · in a monthQ1 2026
Financials
NRX Pharmaceuticals, Inc. FAQ
Common questions about NRX Pharmaceuticals, Inc.
NRX Pharmaceuticals, Inc. is scheduled to report earnings for Q1 2026 on May 14, 2026. Analysts estimate revenue of $37.0M.